Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15032983 | 0.80 | DGAT1 (0.32) | NPC1DGAT1 | |
| SCHEMBL3526518 | 0.79 | NPC1 (0.37) | NPC1DGAT1 | |
| SCHEMBL11617 | 0.76 | FDPS (0.33) | NPC1 | |
| SCHEMBL1344806 | 0.76 | TBXAS1 (0.39) | — | |
| Ammonia Solution, Strong SCHEMBL27898568 | 0.75 | FDPS (0.32) | — | |
| SCHEMBL28496046 | 0.74 | DGAT1 (0.38) | NPC1DGAT1 | |
| SCHEMBL30877301 | 0.72 | DGAT1 (0.34) | NPC1DGAT1 | |
| SCHEMBL10200583 | 0.72 | DGAT1 (0.34) | NPC1DGAT1 | |
| SCHEMBL16611601 | 0.72 | DGAT1 (0.40) | NPC1DGAT1 | |
| SCHEMBL28912548 | 0.72 | DGAT1 (0.34) | NPC1DGAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111048415-B | Selective etching liquid composition and preparation method and application thereof | 上海新阳半导体材料股份有限公司 | 2023-03-14 | — | — | CN | claimed |
| CN-111048415-A | Selective etching liquid composition and preparation method and application thereof | 上海新阳半导体材料股份有限公司 | 2020-04-21 | — | — | CN | claimed |
| CN-117964643-B | Pyrrole [2,3-b ] pyridine derivative and preparation method and application thereof | 苏州朗睿生物医药有限公司 | 2024-07-02 | — | — | CN | disclosed |
| CN-118139864-A | New compounds | 西特瑞治疗有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-117964643-A | Pyrrole [2,3-b ] pyridine derivative and preparation method and application thereof | 苏州朗睿生物医药有限公司 | 2024-05-03 | — | — | CN | disclosed |
| CN-111868037-B | Fused cyclic urea derivatives as CRHR2 antagonists | 拉夸里亚创药株式会社 | 2023-10-13 | — | — | CN | disclosed |
| CN-113620956-B | Transforming growth factor receptor antagonist, preparation method and application thereof | 赛诺哈勃药业（成都）有限公司 | 2023-06-13 | — | — | CN | disclosed |
| CN-116171280-A | Casein kinase 1 delta modulators | 詹森药业有限公司 | 2023-05-26 | — | — | CN | disclosed |
| CN-114072412-B | Tricyclic compound, pharmaceutical composition and application thereof | 深圳铂立健医药有限公司 | 2023-01-10 | — | — | CN | disclosed |
| US-20230002819-A1 | Methods for Biomolecular Sensing and Detection | UNIVERSAL SEQUENCING TECH CORPORATION (US) | 2023-01-05 | — | — | US | disclosed |
| CN-115433184-A | HPK1 inhibitor and application thereof | 武汉人福创新药物研发中心有限公司 | 2022-12-06 | — | — | CN | disclosed |
| CN-113214294-A | Tricyclic compound, pharmaceutical composition and application thereof | 深圳铂立健医药有限公司 | 2021-08-06 | — | — | CN | disclosed |
| CN-113227091-A | As AM2Heterocyclic spiro-compounds as receptor inhibitors | 谢菲尔德大学 | 2021-08-06 | — | — | CN | disclosed |
| CN-107835814-B | Azabenzimidazoles and their use as AMPA receptor modulators | 詹森药业有限公司 | 2021-07-23 | — | — | CN | disclosed |
| WO-2021035221-A1 | METHODS FOR BIOMOLECULAR SENSING AND DETECTION | UNIVERSAL SEQUENCING TECHNOLOGY CORPORATION (US) | 2021-02-25 | — | — | WO | disclosed |
| CN-111868037-A | Fused cyclic urea derivatives as CRHR2 antagonists | 拉夸里亚创药株式会社 | 2020-10-30 | — | — | CN | disclosed |
| CN-111048415-A | Selective etching liquid composition and preparation method and application thereof | 上海新阳半导体材料股份有限公司 | 2020-04-21 | — | — | CN | disclosed |
| CN-110891951-A | Compound (I) | 谢菲尔德大学 | 2020-03-17 | — | — | CN | disclosed |
| EP-1910358-A2 | HETEROCYCLIC JANUS KINASE 3 INHIBITORS | Astellas Pharma Inc. (JP) | 2008-04-16 | — | — | EP | disclosed |
| WO-2007007919-A2 | HETEROCYCLIC JANUS KINASE 3 INHIBITORS | ASTELLAS PHARMA INC. (JP) | 2007-01-18 | — | — | WO | disclosed |